First-In-Human Clinical Trial Aims to Extend Remission for Children and Young Adults With Leukemia Treated With T … – Newswise (press release)
|
First-In-Human Clinical Trial Aims to Extend Remission for Children and Young Adults With Leukemia Treated With T …
Newswise (press release) The new phase 1 pilot study, PLAT-03, will examine the feasibility and safety of administering a second T-cell product intended to increase the long-term persistence of the patient’s chimeric antigen receptor (CAR) T cells that were reprogrammed to … |
Immuno-Oncology News |
SU2C’s Online Education Program Releases Training Modules to Prepare Nurses for Immunotherapy Care
Immuno-Oncology News Stand Up to Cancer (SU2C) has released a new series of training modules to give nurses the skills and knowledge needed in dealing with emerging immunotherapy treatments for cancer patients. Experts from Boston College William F. Connell School of … |
Immuno-Oncology News |
SU2C’s Online Education Program Releases Training Modules to Prepare Nurses for Immunotherapy Care
Immuno-Oncology News Stand Up to Cancer (SU2C) has released a new series of training modules to give nurses the skills and knowledge needed in dealing with emerging immunotherapy treatments for cancer patients. Experts from Boston College William F. Connell School of … |
|
First-In-Human Clinical Trial Aims to Extend Remission for Children and Young Adults With Leukemia Treated With T …
PR Newswire (press release) The new phase 1 pilot study, PLAT-03, will examine the feasibility and safety of administering a second T-cell product intended to increase the long-term persistence of the patient’s chimeric antigen receptor (CAR) T cells that were reprogrammed to … |